1 / 3

UK Inflammatory Bowel Disease (IBD) Market Growth, Size, Share, Industry Report and Forecast 2019-2025

UK IBD market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. IBD is one of the key chronic inflammatory digestive diseases prevalent in the country. The disease is caused by a number of factors including the changing lifestyle of the population, the prevalence of Crohn's disease in the country are a few of the key reasons which are expected to promote the demand of treatment and diagnostic services for IBD.

mansi3210
Download Presentation

UK Inflammatory Bowel Disease (IBD) Market Growth, Size, Share, Industry Report and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research UK Inflammatory Bowel Disease (IBD) Market, Size, Share, Analysis Report & Forecast to 2025 Request https://www.omrglobal.com/request-sample/uk-ibd-inflammatory-bowel-disease-market a Free Sample of our UK Inflammatory Bowel Disease (IBD) Market: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

  2. UK IBD market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. IBD is one of the key chronic inflammatory digestive diseases prevalent in the country. The disease is caused by a number of factors including the changing lifestyle of the population, the prevalence of Crohn's disease in the country are a few of the key reasons which are expected to promote the demand of treatment and diagnostic services for IBD. The research on autoimmune diseases has gained momentum in the UK. Although the inflammatory and immune diseases register only a small portion in the research funding by the public, it is expected to increase in the coming years. For instance, the department of health’ National Institute of health research allocated a budget of $52.6 million in 2014- 2015 for research on inflammatory and immune diseases. This budget also included research on inflammatory diseases in the country. On similar lines, the medical research council also contributed $44.4 million for research on immunology. As these research funding increase in the coming years so as to decrease the mortality rate due to these chronic diseases, it is expected to further increase the opportunities for the market in the near future. A full Report of UK Inflammatory Bowel Disease (IBD) Market is Available at: https://www.omrglobal.com/industry-reports/uk-ibd-inflammatory-bowel-disease-market UK IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. UK IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market is segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti- inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD. Request https://www.omrglobal.com/request-sample/uk-ibd-inflammatory-bowel-disease-market a Free Sample of our UK Inflammatory Bowel Disease (IBD) Market: UKInflammatory Bowel Disease IBD Market Segmentation By Disease Type •Ulcerative Colitis •Crohn’s Disease •UK IBD Market by Diagnostics •Blood and Stool Tests •Endoscopies, •Ultrasound •X-Ray

  3. •UK IBD Market by Therapeutics •Surgery •Anti- Inflammatory Drug Administration •Steroids •Immunosuppressant •Biological Drugs •Amino salicylates •Others Company Profiles •AbbVie Inc. •Allergan, PLC •Boehringer Ingelheim International GmbH •Eli Lilly and Co. •Johnson & Johnson Services Inc. •Pfizer Inc. •Pharmacosmos A/S •Sanofi S.A. •Takeda pharmaceutical Co., Ltd. •UCB, Inc. •Vifor Pharma Group For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/uk-ibd-inflammatory-bowel-disease-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

More Related